Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes
María Julia Montoro(Vall d'Hebron Hospital Universitari), David Valcárcel(Vall d'Hebron Hospital Universitari), Rami S. Komrokji(Moffitt Cancer Center), Pierre Fenaux(Saint Louis University Hospital), Pamela Acha(Josep Carreras Leukaemia Research Institute), Daniel H. Wiseman(University of Manchester), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Beate Betz(Düsseldorf University Hospital), Alessia Campagna(Humanitas University), Lea Naomi Eder(Universitätsmedizin Göttingen), Elisa Diral(Vita-Salute San Raffaele University), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Mara Memoli(Federico II University Hospital), Tariq Kewan(Yale University), Manja Meggendorfer(Université Paris-Sud), Torsten Haferlach(Martin Luther Christian University), Antonella Pollini(Marche Polytechnic University), Austin Kulasekararaj(King's College London), Matteo Della Porta(University of Milan), Francesc Bosch(Vall d'Hebron Hospital Universitari), Mikkael A. Sekeres(University of Miami), Raja Prince-Eladnani(Vall d'Hebron Hospital Universitari), Carmelo Gurnari(University of Rome Tor Vergata), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Najla Al Ali(Moffitt Cancer Center), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Ulrich Germing(Düsseldorf University Hospital), Maria Teresa Voso(University of Rome Tor Vergata), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Amer M. Zeidan(Yale Cancer Center), Esperanza Such(Leitat Technological Center), Felicitas Schulz(Düsseldorf University Hospital), Onyee Chan(Moffitt Cancer Center), Félix López(Vall d'Hebron Hospital Universitari), Nicolás Díaz Varela(Instituto de Investigación Sanitaria del Principado de Asturias), Uwe Platzbecker(National Center for Tumor Diseases), Robert Briski(The University of Texas MD Anderson Cancer Center), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Jaroslaw P. Maciejewski(Cleveland Clinic), Andrés Jerez(Cleveland Clinic), Laura Palomo(Fundación Josep Carreras Contra la Leucemia), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Yasuo Kubota(Cleveland Clinic), Detlef Haase(Universitätsmedizin Göttingen), Yu‐Hung Wang(University of Manchester), C. Zindel(Hôpital Saint-Louis), Aref Al‐Kali(Mayo Clinic)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k